Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 152

1.

EWSR1-NFATC2 Translocation-associated Sarcoma Clinicopathologic Findings in a Rare Aggressive Primary Bone or Soft Tissue Tumor.

Wang GY, Thomas DG, Davis JL, Ng T, Patel RM, Harms PW, Betz BL, Schuetze SM, McHugh JB, Horvai AE, Cho SJ, Lucas DR.

Am J Surg Pathol. 2019 Aug;43(8):1112-1122. doi: 10.1097/PAS.0000000000001260.

PMID:
30994538
2.

Atypical "Sclerosing" Osteoblastic Neoplasm: A Tumor of Intermediate Biological Potential Between Usual Osteoblastoma and Conventional Osteosarcoma.

McHugh KE, Reith JD, Lucas DR, Emory CL, Mesko NW, Kilpatrick SE.

Am J Surg Pathol. 2019 May;43(5):610-617. doi: 10.1097/PAS.0000000000001236.

PMID:
30807304
3.

Phosphaturic Mesenchymal Tumor of the Cerebellopontine Angle.

Walsh EM, Jacob J, Lucas DR, Sargent EW.

JAMA Otolaryngol Head Neck Surg. 2019 Mar 1;145(3):287-288. doi: 10.1001/jamaoto.2018.4045. No abstract available.

PMID:
30703204
4.

Canonical Wnt/β-catenin signaling activation in soft-tissue sarcomas: A comparative study of synovial sarcoma and leiomyosarcoma.

Briski LM, Thomas DG, Patel RM, Lawlor ER, Chugh R, McHugh JB, Lucas DR.

Rare Tumors. 2018 Nov 25;10:2036361318813431. doi: 10.1177/2036361318813431. eCollection 2018.

5.

Histiocytic Sarcoma: Review, Discussion of Transformation From B-Cell Lymphoma, and Differential Diagnosis.

Skala SL, Lucas DR, Dewar R.

Arch Pathol Lab Med. 2018 Nov;142(11):1322-1329. doi: 10.5858/arpa.2018-0220-RA. Review.

PMID:
30407858
6.

Melanotic Neuroectodermal Tumor of Infancy.

Soles BS, Wilson A, Lucas DR, Heider A.

Arch Pathol Lab Med. 2018 Nov;142(11):1358-1363. doi: 10.5858/arpa.2018-0241-RA. Review.

PMID:
30407852
7.

Contributions From University of Michigan 2017 New Frontiers in Pathology Conference.

Smith LB, Westerhoff M, Lucas DR.

Arch Pathol Lab Med. 2018 Oct;142(10):1157-1158. doi: 10.5858/arpa.2018-0320-ED. No abstract available.

PMID:
30281369
8.

Dedifferentiated Liposarcoma With Myofibroblastic Differentiation.

Wang GY, Lucas DR.

Arch Pathol Lab Med. 2018 Oct;142(10):1159-1163. doi: 10.5858/arpa.2018-0205-RA. Review.

PMID:
30281365
9.

The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.

Udager AM, Magers MJ, Goerke DM, Vinco ML, Siddiqui J, Cao X, Lucas DR, Myers JL, Chinnaiyan AM, McHugh JB, Giordano TJ, Else T, Mehra R.

Hum Pathol. 2018 Jan;71:47-54. doi: 10.1016/j.humpath.2017.10.013. Epub 2017 Oct 24.

PMID:
29079178
10.

Myxoinflammatory Fibroblastic Sarcoma: Review and Update.

Lucas DR.

Arch Pathol Lab Med. 2017 Nov;141(11):1503-1507. doi: 10.5858/arpa.2017-0219-RA. Review.

PMID:
29072951
11.

Contributions From University of Michigan 2016 New Frontiers in Pathology Conference.

Smith LB, Lamps LW, Lucas DR.

Arch Pathol Lab Med. 2017 Oct;141(10):1310-1312. doi: 10.5858/arpa.2017-0273-ED. No abstract available.

PMID:
28968155
12.

Solitary Fibrous Tumors of the Head and Neck: A Multi-Institutional Clinicopathologic Study.

Smith SC, Gooding WE, Elkins M, Patel RM, Harms PW, McDaniel AS, Palanisamy N, Uram-Tuculescu C, Balzer BB, Lucas DR, Seethala RR, McHugh JB.

Am J Surg Pathol. 2017 Dec;41(12):1642-1656. doi: 10.1097/PAS.0000000000000940.

13.

The utility of ETV1, ETV4 and ETV5 RNA in-situ hybridization in the diagnosis of CIC-DUX sarcomas.

Smith SC, Palanisamy N, Martin E, Almenara J, McHugh JB, Choi EK, Lucas DR, Betz BL, Thomas D, Patel RM.

Histopathology. 2017 Mar;70(4):657-663. doi: 10.1111/his.13112. Epub 2016 Dec 16.

14.

MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience.

Udager AM, Ishikawa MK, Lucas DR, McHugh JB, Patel RM.

Pathology. 2016 Dec;48(7):697-704. doi: 10.1016/j.pathol.2016.08.007. Epub 2016 Oct 22.

PMID:
27780597
15.

Amygdala and Ventral Striatum Make Distinct Contributions to Reinforcement Learning.

Costa VD, Dal Monte O, Lucas DR, Murray EA, Averbeck BB.

Neuron. 2016 Oct 19;92(2):505-517. doi: 10.1016/j.neuron.2016.09.025. Epub 2016 Oct 6.

16.

Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor.

Schuetze SM, Bolejack V, Choy E, Ganjoo KN, Staddon AP, Chow WA, Tawbi HA, Samuels BL, Patel SR, von Mehren M, D'Amato G, Leu KM, Loeb DM, Forscher CA, Milhem MM, Rushing DA, Lucas DR, Chugh R, Reinke DK, Baker LH.

Cancer. 2017 Jan 1;123(1):90-97. doi: 10.1002/cncr.30379. Epub 2016 Oct 3.

17.

Contributions From the University of Michigan New Frontiers in Pathology 2015 Conference.

Greenson JK, Lucas DR.

Arch Pathol Lab Med. 2016 Oct;140(10):1025. doi: 10.5858/arpa.2016-0244-ED. No abstract available.

PMID:
27684972
18.

Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss.

Lazo de la Vega L, Hovelson DH, Cani AK, Liu CJ, McHugh JB, Lucas DR, Thomas DG, Patel RM, Tomlins SA.

Hum Pathol. 2016 Dec;58:161-170. doi: 10.1016/j.humpath.2016.09.004. Epub 2016 Sep 21.

19.

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.

Davis EJ, Zhao L, Lucas DR, Schuetze SM, Baker LH, Zalupski MM, Thomas D, Chugh R.

BMC Cancer. 2016 Aug 20;16:663. doi: 10.1186/s12885-016-2694-2.

20.

A bivalent promoter contributes to stress-induced plasticity of CXCR4 in Ewing sarcoma.

Krook MA, Hawkins AG, Patel RM, Lucas DR, Van Noord R, Chugh R, Lawlor ER.

Oncotarget. 2016 Sep 20;7(38):61775-61788. doi: 10.18632/oncotarget.11240.

Supplemental Content

Loading ...
Support Center